Cargando…
Using nirmatrelvir/ritonavir in patients with epilepsy: An update from the Israeli chapter of the International League Against Epilepsy
Presented herein are recommendations for use of nirmatrelvir/ritonavir in patients with epilepsy, as issued by the Steering Committee of the Israeli chapter of the International League Against Epilepsy. The recommendations suggest that patients on moderate‐to‐strong enzyme‐inducing antiseizure medic...
Autores principales: | Noyman, Iris, Ekstein, Dana, Fahoum, Firas, Herskovitz, Moshe, Linder, Ilan, Ben Zeev, Bruria, Eyal, Sara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314867/ https://www.ncbi.nlm.nih.gov/pubmed/35239193 http://dx.doi.org/10.1111/epi.17212 |
Ejemplares similares
-
Nirmatrelvir-ritonavir for COVID-19
por: McDonald, Emily G, et al.
Publicado: (2022) -
Nirmatrelvir and ritonavir for COVID-19
Publicado: (2022) -
Nirmatrelvir Plus Ritonavir: First Approval
por: Lamb, Yvette N.
Publicado: (2022) -
Medical Cannabis for Intractable Epilepsy in Childhood: A Review
por: Ben-Zeev, Bruria
Publicado: (2020) -
Asystole in the epilepsy unit
por: Honig, Asaf, et al.
Publicado: (2015)